| 中文名 | N2-[2-甲氧基-4-[4-(4-甲基-1-哌嗪基)-1-哌啶基]苯基]-N4-[2-[(1-甲基乙基)磺酰基]苯基]-1,3,5-三嗪-2,4-二胺 |
|---|---|
| 英文名 | 2-N-[2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]-4-N-(2-propan-2-ylsulfonylphenyl)-1,3,5-triazine-2,4-diamine |
| 英文别名 |
N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine
cc-325 QCR-144 N-{2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}-N'-[2-(propane-2-sulfonyl)phenyl]-1,3,5-triazine-2,4-diamine ASP 3026 N-[2-(isopropylsulfonyl)phenyl]-N'-{2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}-1,3,5-triazine-2,4-diamine 1,3,5-Triazine-2,4-diamine, N-[2-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N-[2-[(1-methylethyl)sulfonyl]phenyl]- CS-0787 UNII-HP4L6MXF10 N-[2-(Isopropylsulfonyl)phenyl]-N'-{2-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl}-1,3,5-triazine-2,4-diamine ASP3026 |
| 描述 | ASP3026是高活性ALK抑制剂,IC50为3.5 nM。 |
|---|---|
| 相关类别 | |
| 参考文献 |
[1]. Sadao Kuromitsu, et al. AACR 102nd Annual Meeting, 2011. |
| 密度 | 1.3±0.1 g/cm3 |
|---|---|
| 沸点 | 794.3±70.0 °C at 760 mmHg |
| 分子式 | C29H40N8O3S |
| 分子量 | 580.745 |
| 闪点 | 434.2±35.7 °C |
| 精确质量 | 580.294434 |
| PSA | 127.43000 |
| LogP | 1.01 |
| 蒸汽压 | 0.0±2.8 mmHg at 25°C |
| 折射率 | 1.620 |
| 储存条件 | -20°C |
|
~85%
1097917-15-1 |
| 文献:Astellas Pharma Inc.; OBITSU, Kazuyoshi; AKIBA, Takahiro; KOBAYASHI, Koji; HIRASAWA, Shun; KONDOH, Yutaka; TAKEGUCHI, Kazuhiro; TAKAHAMA, Yuji; ORII, Ryoki Patent: EP2669281 A1, 2013 ; Location in patent: Paragraph 0059 ; |
|
~%
1097917-15-1 |
| 文献:EP2669281 A1, ; |
|
~%
1097917-15-1 |
| 文献:EP2669281 A1, ; |
|
~%
1097917-15-1 |
| 文献:EP2669281 A1, ; |
|
~%
1097917-15-1 |
| 文献:EP2669281 A1, ; |
|
~%
1097917-15-1 |
| 文献:EP2669281 A1, ; |
|
~%
1097917-15-1 |
| 文献:EP2669281 A1, ; |
|
~%
1097917-15-1 |
| 文献:EP2669281 A1, ; |
| 上游产品 9 | |
|---|---|
| 下游产品 0 | |